No evidence of harmful effects of steroids in severe exacerbations of COPD associated with influenza-Reference-Cited by-同舟云学术

No evidence of harmful effects of steroids in severe exacerbations of COPD associated with influenza

Published:2022-01-29 Issue:3 Volume:50 Page:699-707
ISSN:0300-8126
Container-title:Infection
language:en
Short-container-title:Infection

Author:

Studer Severin,Rassouli Frank,Waldeck Frederike,Brutsche Martin H.,Baty Florent,Albrich Werner C.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s15010-021-01743-1.pdf

Reference39 articles.

1. Soriano JB, Abajobir AA, Abate KH, Abera SF, Agrawal A, Ahmed MB, et al. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the global burden of disease study 2015. Lancet Respir Med. 2017;5:691–706. https://doi.org/10.1016/S2213-2600(17)30293-X (Internet).

2. Hoyert DL, Xu J. Deaths: preliminary data for 2011. Natl Vital Stat Rep [Internet]. 2012;61:1–51. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24984457. Accessed 27 Dec 2021

3. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012;380:2095–128. https://doi.org/10.1016/S0140-6736(12)61728-0 (Internet).

4. Ray S, Guarascio, Finch ST. The clinical and economic burden of chronic obstructive pulmonary disease in the USA. Clin Outcomes Res. 2013;5:235. https://doi.org/10.2147/CEOR.S34321.

5. Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, et al. International variation in the prevalence of COPD (the bold study): a population-based prevalence study. Lancet. 2007;370:741–50.